R&D Systems™ Recombinant Human BTNL10/Butyrophilin-like 10 Fc Protein

Catalog No.	Quantity
10-014-BT050	50 μg

Catalog No. 10-014-BT050 Supplier R&D Systems™ Supplier No. 10014BT050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Measured by its ability to inhibit anti-CD3 antibody induced IFN-gamma secretion by human peripheral blood mononuclear cells (PBMC). The ED50 for this effect is 1.5-7.5 μg/mL.

Specifications

• Accession Number: A8MVZ5
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 100129094
• Molecular Weight (g/mol): M.W. (Observed): 48-55 kDa & 96-108 kDa (non-reducible dimer), reducing conditions; M.W. (theoretical): 40.6 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell, HEK293-derived human BTNL10 protein Human BTNL10 (Ser27-Gly149) (N-terminus) Accession # A8MVZ5 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: 12 months from date of receipt, <= -20 °C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, <= -20 °C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Specific Reactivity: BTNL10
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 200 μg/mL in PBS.
• Buffer: Lyophilized from a 0.2 μm filtered solution in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: BTNL10